Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOXGet Free Report) was the recipient of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 280,500 shares, a decline of 18.1% from the March 31st total of 342,600 shares. Approximately 0.9% of the company’s shares are short sold. Based on an average daily trading volume, of 63,900 shares, the days-to-cover ratio is presently 4.4 days.

Analyst Ratings Changes

Separately, Roth Mkm upped their target price on Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research report on Friday, February 9th.

Check Out Our Latest Stock Report on BIOX

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in BIOX. Raymond James & Associates boosted its stake in Bioceres Crop Solutions by 4.9% in the 3rd quarter. Raymond James & Associates now owns 27,567 shares of the company’s stock worth $311,000 after purchasing an additional 1,300 shares during the period. Federated Hermes Inc. raised its holdings in shares of Bioceres Crop Solutions by 8.5% in the 3rd quarter. Federated Hermes Inc. now owns 141,684 shares of the company’s stock valued at $1,600,000 after acquiring an additional 11,057 shares in the last quarter. Ballast Asset Management LP purchased a new stake in shares of Bioceres Crop Solutions in the 3rd quarter valued at about $2,210,000. Polar Capital Holdings Plc purchased a new stake in shares of Bioceres Crop Solutions in the 3rd quarter valued at about $2,112,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Bioceres Crop Solutions by 46.7% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company’s stock valued at $1,876,000 after acquiring an additional 43,484 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Up 0.2 %

Shares of NASDAQ:BIOX traded up $0.02 during trading on Monday, reaching $12.07. 17,716 shares of the stock were exchanged, compared to its average volume of 59,516. The firm has a market cap of $758.00 million, a price-to-earnings ratio of 37.66 and a beta of 0.58. The stock has a fifty day moving average of $12.72 and a two-hundred day moving average of $12.55. Bioceres Crop Solutions has a 1-year low of $9.76 and a 1-year high of $14.20. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.84.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last posted its quarterly earnings results on Thursday, February 8th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.02. The company had revenue of $140.30 million during the quarter, compared to the consensus estimate of $108.97 million. Bioceres Crop Solutions had a return on equity of 5.96% and a net margin of 4.36%. During the same quarter in the prior year, the company earned ($0.14) EPS. Research analysts anticipate that Bioceres Crop Solutions will post 0.45 earnings per share for the current fiscal year.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Read More

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.